227 related articles for article (PubMed ID: 17458898)
1. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells.
Li X; Chen D; Yin S; Meng Y; Yang H; Landis-Piwowar KR; Li Y; Sarkar FH; Reddy GP; Dou QP; Sheng S
J Cell Physiol; 2007 Aug; 212(2):298-306. PubMed ID: 17458898
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein.
Yoshida T; Shiraishi T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T
Cancer Res; 2005 Jul; 65(13):5662-7. PubMed ID: 15994939
[TBL] [Abstract][Full Text] [Related]
3. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
Ma L; Shen YY; Zhou P; Zhou J; Guo F
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
[TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
[TBL] [Abstract][Full Text] [Related]
5. Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines.
Guo F; Kang S; Zhou P; Guo L; Ma L; Hou J
Mol Immunol; 2011 Oct; 49(1-2):8-17. PubMed ID: 21856005
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
Liu HF; Hu HC; Chao JI
Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
[TBL] [Abstract][Full Text] [Related]
8. [Up-regulates the expression of maspin gene in prostate cancer cell line LNCaP].
Shi P; Chen WW; Hu XY; Yu CX; Zhang PJ; Jiang AL; Zhang JY
Yao Xue Xue Bao; 2006 Dec; 41(12):1152-6. PubMed ID: 17290611
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
10. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
[TBL] [Abstract][Full Text] [Related]
12. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
[TBL] [Abstract][Full Text] [Related]
13. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
[TBL] [Abstract][Full Text] [Related]
14. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells.
Yerlikaya A; DoKudur H
Mol Biol (Mosk); 2010; 44(5):859-66. PubMed ID: 21090173
[TBL] [Abstract][Full Text] [Related]
16. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
Zou Z; Zhang W; Young D; Gleave MG; Rennie P; Connell T; Connelly R; Moul J; Srivastava S; Sesterhenn I
Clin Cancer Res; 2002 May; 8(5):1172-7. PubMed ID: 12006534
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-κB and CHOP expression.
Huong PT; Moon DO; Kim SO; Kim KE; Jeong SJ; Lee KW; Lee KS; Jang JH; Erikson RL; Ahn JS; Kim BY
Cell Signal; 2011 May; 23(5):857-65. PubMed ID: 21276850
[TBL] [Abstract][Full Text] [Related]
19. Involvement of AP-1 in p38MAPK signaling pathway in osteoblast apoptosis induced by high glucose.
Feng ZP; Deng HC; Jiang R; Du J; Cheng DY
Genet Mol Res; 2015 Apr; 14(2):3149-59. PubMed ID: 25966080
[TBL] [Abstract][Full Text] [Related]
20. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.
An J; Sun YP; Adams J; Fisher M; Belldegrun A; Rettig MB
Clin Cancer Res; 2003 Oct; 9(12):4537-45. PubMed ID: 14555528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
